IRIS
QUARTUCCIO, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.796
EU - Europa 2.764
AS - Asia 735
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 5
OC - Oceania 2
Totale 14.346
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.740
UA - Ucraina 1.038
DE - Germania 422
CN - Cina 419
IT - Italia 399
FI - Finlandia 270
IE - Irlanda 235
SE - Svezia 195
TR - Turchia 139
GB - Regno Unito 114
VN - Vietnam 80
CA - Canada 55
IN - India 32
IR - Iran 24
FR - Francia 23
TG - Togo 19
BE - Belgio 18
JP - Giappone 14
EG - Egitto 12
HK - Hong Kong 12
PL - Polonia 11
EU - Europa 6
KR - Corea 6
RU - Federazione Russa 6
ES - Italia 5
RO - Romania 5
EE - Estonia 4
NL - Olanda 4
CL - Cile 3
TW - Taiwan 3
ZA - Sudafrica 3
AL - Albania 2
AT - Austria 2
CH - Svizzera 2
IL - Israele 2
MA - Marocco 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BO - Bolivia 1
BR - Brasile 1
ET - Etiopia 1
GR - Grecia 1
HR - Croazia 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SA - Arabia Saudita 1
SG - Singapore 1
TH - Thailandia 1
ZM - Zambia 1
Totale 14.346
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.633
Ann Arbor 1.122
Fairfield 1.060
Houston 952
Chandler 767
Jacksonville 678
Wilmington 519
Ashburn 514
Seattle 431
Dearborn 414
Cambridge 335
Dublin 232
Beijing 229
Princeton 229
Udine 171
Izmir 137
Dong Ket 80
San Diego 78
Boardman 63
Des Moines 60
Ogden 60
Norwalk 50
Redmond 41
Ottawa 40
Nanjing 36
Hefei 29
San Mateo 26
Trieste 23
New York 20
Lomé 19
Brussels 17
Auburn Hills 15
Falls Church 15
Kunming 15
Milan 13
Toronto 13
Augusta 12
London 12
Grafing 11
Guangzhou 11
Leawood 11
Simi Valley 11
Chengdu 10
Saint Louis 10
Warsaw 10
Ardabil 9
Nanchang 9
Phoenix 9
Hong Kong 8
Jinan 8
Redwood City 8
Wuhan 8
Mumbai 7
Rome 7
Fuzhou 6
Los Angeles 6
Monmouth Junction 6
Paris 6
Shenyang 6
Xian 6
Andover 5
Edinburgh 5
Hangzhou 5
Helsinki 5
Maserada Sul Piave 5
Washington 5
Baotou 4
Cagliari 4
Chicago 4
Codroipo 4
Indiana 4
New Orleans 4
Tallinn 4
Tappahannock 4
Verona 4
Vicenza 4
Albolote 3
Amsterdam 3
Buffalo 3
Dallas 3
Menlo Park 3
Pisa 3
Quzhou 3
Rovigo 3
Saint Petersburg 3
Shanghai 3
Tavagnacco 3
Tokyo 3
Venezia 3
Zhengzhou 3
Al Qahirah al Jadidah 2
Alexandria 2
Almada 2
Ansbach 2
Atlanta 2
Cairo 2
Campagnola Cremasca 2
Cernobbio 2
Chongqing 2
Columbus 2
Totale 10.475
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 152
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 146
Validation of the classification criteria for cryoglobulinaemic vasculitis. 137
Pain management in cryoglobulinaemic syndrome 137
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 133
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 129
Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study. 126
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 126
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides. 123
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 123
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 122
Use of teriparatide in osteoporosis due to active rheumatic diseases 121
Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs 120
Apheresis treatment of cryoglobulinemic vasculitis: A multicentre cohort study of 159 patients 120
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 118
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 118
Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands 116
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 116
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 116
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 114
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 113
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study. 113
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 112
Patient-reported impact of spondyloarthritis on work disability and working life: The ATLANTIS survey 112
Pachydermodactyly: The role of ultrasonography and dermoscopy for diagnosis 112
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 111
Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring. 110
Development of the ClinESSDAI: A clinical score without biological domain. A tool for biological studies 110
HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2 109
Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients 108
Accuracy of Computer-Guided Flapless Implant Surgery in Fully Edentulous Arches and in Edentulous Arches With Fresh Extraction Sockets 107
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 106
Classification of cryoglobulinemic vasculitis 105
Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection 105
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 103
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 102
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 101
Treatment of rheumatoid arthritis with rituximab: an update and possible indications. 101
Acetaminophen-induced liver injury in a woman with febrile flare of systemic lupus erythematosus 101
L. Quartuccio, M. Fabris, M. Maset, E. Pontarini, A. Zabotti, S. De Vita Bone marrow b-cell expansion in mixed cryoglobulinemia: association with nephritis and response to rituximab 100
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. 100
Gastrointestinal Involvement in Systemic Vasculitis 100
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 99
B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis 98
Strontium ranelate and femural fracture healing during rheumatoid arthritis and osteoporosis 97
Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al 97
Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis 97
Dermoscopy of nail fold and elbow in the differential diagnosis of early psoriatic arthritis sine psoriasis and early rheumatoid arthritis 95
Variations in lumbar and femural bmd after rituximab therapy in active rheumatoid arthritis 94
A B-cell activating factor receptor (BAFF-R) His159Tyr mutation in Sjögren's Syndrome related lymphoproliferation 94
Mycophenolic Acid AUC estimation in patients with lupus nephritis using an algorithm validated in an heart transplanted population 94
Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer 94
Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome 93
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. 92
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 92
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 91
efficacy of methotrexate in polymyalgia rheumatica 90
Efficacy and tolerability of repeated cycles of a once-weekly regimen of bortezomib in lupus. 90
Preliminary classification criteria for the cryoglobulinaemic vasculitis 90
Delayed Positivization of Cerebral Angiography in Reversible Cerebral Vasoconstriction Syndrome (RCVS) Presenting with Recurrent Subarachnoid Haemorrhage. 90
Pleuritis is a red flag for Adult-onset Still's disease which may require biologic therapies. 89
A randomized, controlled, multicenter phase III study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) 89
A randomized, controlled, multicenter phase iii study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) Ann Rheum Dis 2010;69(Suppl3):93 89
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 88
Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab. 87
A randomized controlled trial of rituximab for treatment of severe cryoglobulinemic vasculitis. 87
Pregnancy and fetal outcome in patients with an established diagnosis of primary sjögren's syndrome 85
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 2008 85
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study 85
High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type. 84
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients 84
Myositis in primary sjögren's syndrome: data from a multicenter cohort 83
B-Lymphocyte Stimulator (BLyS) in mixed cryoglobulinemia sindrome: pathobiological and clinical implication 83
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study 83
The-308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis 83
Fetal Outcome in Patients with an Established Diagnosis of Primary Sjögren’s Syndrome 82
Primary sjögren's syndrome as a multi-organ disease: Impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients 81
prevalence of chlamydophila psittaci subclinical infection in italian patients with rheumatoid arthritis: etiopathological and therapeutic implications 80
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis 80
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 79
Rituximab as possible first-line therapy for glomerulonephritis in HCV-related mixed cryoglobulinaemia 78
The role of the il-6 promoter p in predicting rituximab efficacy in rheumatoid artolymorphism 78
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients 78
Early Psoriatic Arthritis Versus Early Seronegative Rheumatoid Arthritis: Role of Dermoscopy Combined with Ultrasonography for Differential Diagnosis 77
Efficacy of Belimumab On Non-Malignant Parotid Swelling and Systemic Manifestations of Sjo¨gren’s Syndrome: Results of the Beliss Study. 76
Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes 76
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia. 2007; 66 (Suppl. II): 121 75
Articular and peripheral nervous system involvement are linked to the long-term outcome in primary Sjögren's syndrome: The relevance of single organ manifestations rather than a composite score as predictors 75
Gastrointestinal involvement in systemic vasculitis 75
Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy. 74
Is salivary gland ultrasonography a useful tool in Sjögren's syndrome? A systematic review 74
A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy 74
Cryoglobulinemia in Sjögren Syndrome: A Disease Subset that Links Higher Systemic Disease Activity, Autoimmunity, and Local B Cell Proliferation in Mucosa-associated Lymphoid Tissue 73
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 73
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome. 72
Rituximab in mixed cryoglobulinemia: increased experience and perspectives 72
Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus 72
Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis: reply 71
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia. 71
Long-term response to rituximab in 36 patents with the reumatoid arthritis: a single centre wxperience. 70
Totale 9.711
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.606
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019806 0 0 0 0 0 0 0 0 0 136 440 230
2019/20203.400 135 150 104 470 235 585 401 412 254 319 91 244
2020/20212.489 78 270 52 274 103 275 67 258 527 84 325 176
2021/20221.678 62 173 89 138 44 48 91 109 25 235 369 295
2022/20232.028 248 95 38 221 208 544 35 147 290 38 77 87
2023/2024681 108 62 29 19 143 89 30 64 99 38 0 0
Totale 15.101